Next, we aimed to uncover the mechanism underlying KRAS/ERK/ALKBH5 PTMs/ DDB2 and XPC signaling axis-mediated platinum resistance in NSCLC cells. This evidence concerns the gene KRAS and non-small cell lung carcinoma.